These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21640048)

  • 1. Adjusted prophylactic doses of nadroparin plus low dose aspirin therapy in obstetric antiphospholipid syndrome. A prospective cohort management study.
    Ruffatti A; Gervasi MT; Favaro M; Ruffatti AT; Hoxha A; Punzi L
    Clin Exp Rheumatol; 2011; 29(3):551-4. PubMed ID: 21640048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort study.
    Ruffatti A; Favaro M; Tonello M; De Silvestro G; Pengo V; Fais G; Suma V; Chiarelli S; Todesco S
    Lupus; 2005; 14(2):120-8. PubMed ID: 15751816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.
    Yelnik CM; Lambert M; Drumez E; Le Guern V; Bacri JL; Guerra MM; Laskin CA; Branch DW; Sammaritano LR; Morel N; Guettrot-Imbert G; Launay D; Hachulla E; Hatron PY; Salmon JE; Costedoat-Chalumeau N
    Lupus; 2018 Sep; 27(10):1679-1686. PubMed ID: 30016929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
    Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.
    Hoxha A; Favaro M; Calligaro A; Del Ross T; Ruffatti AT; Infantolino C; Tonello M; Mattia E; Ruffatti A
    Thromb Haemost; 2020 Jan; 120(1):36-43. PubMed ID: 31634958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA].
    Neikova K ; Dimitrova V; Dimitrov R; Savov A
    Akush Ginekol (Sofiia); 2015; 54(5):3-12. PubMed ID: 26411189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.
    Lefkou E; Mamopoulos A; Dagklis T; Vosnakis C; Rousso D; Girardi G
    J Clin Invest; 2016 Aug; 126(8):2933-40. PubMed ID: 27454295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
    Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of therapeutic interventions for recurrent pregnancy loss in association with antiphospholipid syndrome: A systematic review and network meta-analysis.
    Liu X; Qiu Y; Yu ED; Xiang S; Meng R; Niu KF; Zhu H
    Am J Reprod Immunol; 2020 Apr; 83(4):e13219. PubMed ID: 31872490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the low-molecular-weight heparin nadroparin during pregnancy. A review.
    Makatsaria AD; Bitsadze VO; Dolgushina NV
    Curr Med Res Opin; 2003; 19(1):4-12. PubMed ID: 12661774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
    Farquharson RG; Quenby S; Greaves M
    Obstet Gynecol; 2002 Sep; 100(3):408-13. PubMed ID: 12220757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study.
    Bouvier S; Cochery-Nouvellon E; Lavigne-Lissalde G; Mercier E; Marchetti T; Balducchi JP; Marès P; Gris JC
    Blood; 2014 Jan; 123(3):404-13. PubMed ID: 24200687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels.
    Shi T; Gu ZD; Diao QZ
    Medicine (Baltimore); 2021 Jun; 100(25):e26264. PubMed ID: 34160390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The obstetric outcome following treatment in a cohort of patients with antiphospholipid antibody syndrome in a tertiary care center.
    Dadhwal V; Sharma AK; Deka D; Gupta B; Mittal S
    J Postgrad Med; 2011; 57(1):16-9. PubMed ID: 21206127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin.
    Glasnović M; Bosnjak I; Vcev A; Soldo I; Kosuta M; Lenz B; Glasnović-Horvatić E; Soldo-Butković S; Mićunović N
    Coll Antropol; 2007 Mar; 31(1):173-7. PubMed ID: 17598397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
    Lazzaroni MG; Fredi M; Andreoli L; Chighizola CB; Del Ross T; Gerosa M; Kuzenko A; Raimondo MG; Lojacono A; Ramazzotto F; Zatti S; Trespidi L; Meroni PL; Pengo V; Ruffatti A; Tincani A
    Front Immunol; 2019; 10():1948. PubMed ID: 31475009
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome.
    Bao SH; Sheng SL; Liao H; Zhou Q; Frempong ST; Tu WY
    Am J Reprod Immunol; 2017 Dec; 78(6):. PubMed ID: 29024233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.